Prior to joining Ballast Point Ventures in 2004, Matt Rice began his career in the Health Care Investment Banking Group of Raymond James Financial, where he focused primarily on the specialty pharmaceutical, drug distribution, and contract research organization sectors. Matt also worked in the Strategic Alliances group at the Novartis Institutes for BioMedical Research prior to rejoining Ballast Point Ventures as a Vice President in 2008.
In addition to serving on the Board of Directors of BioTissue, Matt currently serves on the Board of Directors at MolecularMD, Y-Prime, MeYou Health, Theragen, Iconixx, IRIS, and previously represented BPV at Innocutis. Matt leads Ballast Point Venture’s health care practice and also serves on the St. Joseph’s Hospitals Board of Directors (Baycare Health System). Matt holds a Bachelor’s Degree in Commerce from the University of Virginia and a Master’s of Business Administration from the Harvard Graduate School of Business Administration.